This analysis examines the historical and forecast performance for Nycomed in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information.
Key reasons to purchase this title
- Benchmark Nycomed's performance against key rivals in the prescription pharmaceutical sector
- Determine the historical impact of M&A on Nycomed's specialty pharmaceutical business model
- Examine Nycomed's growth potential in the face of a blockbuster patent expiry
